Edwards Lifesciences (EW) 4: Lippis Daniel J. bought 12,820 shares of Common Stock at $N… (Feb 17, 2026)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-02-12 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Lippis Daniel J. CIK: 0002004380 Role: Officer (CVP, TAVR) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-02-12 | Code: A (Grant or award) Shares: +12,820 | Price: $0.00 Shares Owned After: 34,821.9103 | Ownership: D (Direct) Footnotes: [F1] These restricted stock units were granted on February 12, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. [Transaction #2] Security: Common Stock Date: 2026-02-16 | Code: F (Payment of exercise/tax) Shares: -258 | Price: $75.87 Total Value: $19,574.46 Shares Owned After: 34,563.9103 | Ownership: D (Direct) [Transaction #3] Security: Common Stock Date: 2026-02-17 | Code: F (Payment of exercise/tax) Shares: -198 | Price: $75.87 Total Value: $15,022.26 Shares Owned After: 34,365.9103 | Ownership: D (Direct) --- Footnotes (Complete Index) --- F1: These restricted stock units were granted on February 12, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-02-17)